Compare PFE & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PFE | ABT |
|---|---|---|
| Founded | 1849 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.6B | 222.8B |
| IPO Year | N/A | N/A |
| Metric | PFE | ABT |
|---|---|---|
| Price | $25.70 | $122.08 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 18 |
| Target Price | $27.18 | ★ $147.56 |
| AVG Volume (30 Days) | ★ 43.6M | 6.0M |
| Earning Date | 02-03-2026 | 01-22-2026 |
| Dividend Yield | ★ 6.71% | 2.07% |
| EPS Growth | 131.89 | ★ 141.97 |
| EPS | 1.73 | ★ 7.96 |
| Revenue | ★ $62,785,000,000.00 | $43,843,000,000.00 |
| Revenue This Year | N/A | $7.57 |
| Revenue Next Year | N/A | $7.99 |
| P/E Ratio | ★ $14.91 | $15.29 |
| Revenue Growth | 3.89 | ★ 6.37 |
| 52 Week Low | $20.92 | $111.02 |
| 52 Week High | $27.69 | $141.23 |
| Indicator | PFE | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 55.61 | 38.11 |
| Support Level | $24.97 | $122.20 |
| Resistance Level | $25.77 | $125.09 |
| Average True Range (ATR) | 0.44 | 2.11 |
| MACD | 0.06 | -0.28 |
| Stochastic Oscillator | 71.91 | 2.95 |
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.